Cocrystal Pharma (COCP) Total Debt (2010 - 2013)

Cocrystal Pharma (COCP) has 4 years of Total Debt data on file, last reported at $2.9 million in Q3 2013.

• For the quarter ending Q3 2013, Total Debt fell 5.73% year-over-year to $2.9 million; the trailing twelve-month figure through Sep 2013 stood at $2.9 million (down 5.73% YoY), and the FY2012 full-year result was $3.3 million, down 8.46% from the prior year.
• Total Debt declined to $2.9 million in Q3 2013, from $3.1 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $3.6 million in Q4 2011 to a low of $2.9 million in Q3 2013.
• A 4-year average of $3.3 million and a median of $3.3 million in 2010 frame the typical range for Total Debt.
• Across the five-year window, Total Debt climbed 7.16% in 2011 and slipped 8.46% in 2012, its largest moves.
• Tracing COCP's Total Debt over 4 years: stood at $3.3 million in 2010, then increased by 7.16% to $3.6 million in 2011, then fell by 8.46% to $3.3 million in 2012, then fell by 10.08% to $2.9 million in 2013.
• Business Quant data shows COCP's Total Debt at $2.9 million in Q3 2013, $3.1 million in Q2 2013, and $3.4 million in Q1 2013.